A Novel Insertion Mutation on Exon 20 of Epidermal Growth Factor Receptor, Conferring Resistance to Erlotinib

Publisher： Karger

E-ISSN： 1662-6575|7|2|491-496

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-07, pp. : 491-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3212-3220

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2570-2577

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1446-1456

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel 1297-1304delGCCTGCCA Mutation in the Exon 10 of the Thyroid Hormone Receptor Gene Causes Resistance to Thyroid Hormone

By Rivolta Carina M.  

Molecular Diagnosis, Vol. 8, Iss. 3, 2004-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite

Napsin A and Thyroid Transcription Factor-1-Positive Cerebellar Tumor with Epidermal Growth Factor Receptor Mutation

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-12 ,pp. : 564-568

Karger

Access to resources Recommend Favorite